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ABSTRACT
A current goal of molecular biology is to identify transcriptional
networks that regulate cell differentiation. However, identifying
functional gene regulatory elements has been challenging in the
context of developing tissues where material is limited and cell types
are mixed. To identify regulatory sites during sex determination, we
subjected Sertoli cells from mouse fetal testes to DNaseI-seq and
ChIP-seq for H3K27ac. DNaseI-seq identified putative regulatory
sites around genes enriched in Sertoli and pregranulosa cells;
however, active enhancers marked by H3K27ac were enriched
proximal to only Sertoli-enriched genes. Sequence analysis identified
putative binding sites of known and novel transcription factors likely
controlling Sertoli cell differentiation. As a validation of this approach,
we identified a novel Sertoli cell enhancer upstream ofWt1, and used
it to drive expression of a transgenic reporter in Sertoli cells. This work
furthers our understanding of the complex genetic network that
underlies sex determination and identifies regions that potentially
harbor non-coding mutations underlying disorders of sexual
development.
KEY WORDS: Genome-wide enhancer profiling, Sex determination,
Sertoli cell development, Mouse
INTRODUCTION
During development, multipotent progenitor cell commitment to
one cell fate versus another is driven by complex gene networks
controlled by diverse regulatory factors, including transcription
factors (TFs), chromatin remodelers and non-coding RNAs
(ncRNAs). Although identification of the cohorts of genes that
drive cell fate determination is an important focus of developmental
studies, it is equally important to identify the regulatory sites
through which these factors operate. Mutations of regulatory sites in
enhancers and promoters that alter gene expression have been
discovered serendipitously, but until recently, an unbiased genome-
wide approach to identify regulatory elements in specific fetal cell
types remained difficult. Thus, it has not been clear how the
accessibility of chromatin sites and the availability of TFs act
together to control cell fate decisions during fetal development from
a pluripotent to a committed fate.
The developing gonad is a powerful model system for
understanding the gene regulatory mechanisms that drive cell fate
determination. The process of sex determination occurs in gonad
progenitor cells whose differentiation controls the sexual fate of the
organism. Although genetic sex (XY/XX) is established upon
fertilization, these innate chromosomal differences do not produce
phenotypic differences in male or female early embryos (Eggers and
Sinclair, 2012). Instead, sexual dimorphism is initiated in the early
gonad supporting cells, a single cell lineage that differentiates into
Sertoli (XY) (Sekido et al., 2004) or pregranulosa (XX) cells (Albrecht
and Eicher, 2001; Mork et al., 2012). Prior to sex determination, XX
and XY supporting cells are bipotential and express nearly all genes at
similar levels, with minor differences limited to genes on the X and Y
chromosomes (Nef et al., 2003; Munger et al., 2013).
In themouse, male sex determination is initiated around embryonic
day 11.5 (E11.5) by expression of the Y-linked gene Sry, which
diverts XY supporting cells to the Sertoli cell fate (Fig. 1A). Sry is
transiently expressed and many SRY-binding sites are subsequently
bound by its downstream target SOX9 (Li et al., 2014). SRY and
SOX9 control the differentiation of Sertoli cells by triggering a
dramatic transcriptional reprogramming of bipotential progenitor
cells within just 24 h, leading to the upregulation of over 200 genes
important for Sertoli cell development and downregulation of ∼100
pregranulosa cell-expressed genes that were expressed at the
bipotential stage (Munger et al., 2013). In the absence of Sry, XX
supporting cells differentiate to pregranulosa cells, but in contrast to
the dramatic transcriptional changes that accompany Sertoli cell
specification, pregranulosa cell differentiation proceeds with fewer
transcriptional changes consistent with the finding that
undifferentiated XX and XY supporting cells are initially
transcriptionally biased toward ovarian fate (Jameson et al., 2012b).
Although SRY acts as a pivotal switch in the sex-determining
pathway, mutations in SRY account for only ∼10-15%, of XY
disorders of sex development (DSDs) (Cameron and Sinclair, 1997).
Over 35 other genes have been identified that contribute to DSDs
(Arboleda and Vilain, 2011; Arboleda et al., 2013), suggesting that a
complex genetic network controls fate commitment in the early
gonad. It is evident from human DSD cases where gene dose is altered
by duplications or haploinsufficiencies (Foster et al., 1994; Muscatelli
et al., 1994; Zanaria et al., 1994; Jordan et al., 2001) that perturbations
to the level or timing of individual genes within this network can lead
to sex reversals. In the C57BL/6J inbred mouse strain, the altered
expression of several sex-determining genes causes unique strain-
dependent sex-reversal phenotypes in response to specific mutations
(Colvin et al., 2001; Bouma et al., 2005; Kim et al., 2007b; Munger
et al., 2009, 2013; Correa et al., 2012;Warr et al., 2012). These studies
point to the importance of precise spatial and temporal geneReceived 1 August 2016; Accepted 30 December 2016
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regulation. However, our lack of knowledge regarding the locations of
crucial gene-regulatory sites limits our ability to study the regulatory
mechanisms that control gene expression in Sertoli cells.
To identify putative regulatory sites in Sertoli cells, we performed
DNaseI-seq on purified Sertoli cells from fetal testes just after sex
determination. Comparison with DNaseI-seq data from a variety of
other mouse tissues and cell types revealed thousands of novel Sertoli
cell-specific putative regulatory elements, which are enriched near
genes expressed in Sertoli cells, as well as genes that are silent in
Sertoli cells, but expressed in the alternate pregranulosa cell lineage.
This suggests that DNaseI-seq identified sites involved in the
activation and repression of genes required for Sertoli cell fate
commitment. Using ChIP-seq for H3K27ac, we located active
enhancer elements specifically enriched near genes expressed in
Sertoli cells, and used this data to identify TF motifs that distinguish
active from inactive enhancers. Finally, we validated the enhancer
activity of an active regulatory element located 50 kb upstream of
Wt1, which encodes a TF essential for early gonad development. This
data will enable future experiments to characterize the regulatory
network driving Sertoli cell development and may aid in the
identification of non-coding human mutations underlying
unexplained cases of DSDs, the majority of which cannot be
attributed to mutation within the coding region of a known sex-
determining gene (Arboleda and Vilain, 2011; Arboleda et al., 2013).
RESULTS
Adapting DNase1-seq to developmentally limited cell
populations
We conducted a proof-of-principle experiment to establish the
efficacy of DNaseI-seq in identifying regulatory elements in Sertoli
cells that had been purified by fluorescence-activated cell sorting
(FACS) followed by long-term storage at−80°C. E15.5 Sertoli cells
were isolated by FACS based on the Sertoli cell-specific expression
of the Sox9-CFP transgene (Fig. 1A). Significantly reducing the
starting material required, we found that 5×106 cells routinely
yielded enough chromatin to perform the DNaseI-seq assay.
DNaseI-seq identified over 81,000 DNaseI hypersensitive sites
(DHSs) in E15.5 Sertoli cells. Using previously published methods
Fig. 1. DNaseI-seq and RNA-seq analysis of Sertoli cells. (A) Overview of sex determination. At the bipotential stage (E11.5), XX and XY gonads are
indistinguishable and contain a mixture of somatic and germ cells (yellow). The supporting cell lineage (green) gives rise to Sertoli cells of the testis (XY; blue) or
pregranulosa cells of the ovary (XX; pink) upon sex determination. Confocal images show a whole-mount immunostained E13.5 ovary (top) and testis (bottom).
XX pregranulosa cells express the Sry-eGFP transgene (Albrecht and Eicher, 2001) (pink), XY Sertoli cells express the Sox9-CFP transgene (blue; germ cells
and vasculature are yellow/green). Microarray data were previously collected from FACS-isolated E13.5 pregranulosa cells, Sertoli cells and germ cells (Jameson
et al., 2012b). DNaseI-seq was performed on FACS-isolated E13.5 and E15.5 Sertoli cells. RNA-seq was performed on E15.5 Sertoli cells. (B,C) DNaseI-seq
data identified a strong DHS at (B) the Sox9 promoter (expressed in Sertoli cells) and a weaker DHS at (C) the Foxl2 promoter (repressed in Sertoli cells). Only
peaks overlapping the TSS are shown and gene names are positioned adjacent to the TSS. Nearby genes are indicated in gray. Black bars under the gene
indicate DHSs. The top track indicates the Parzen score, or DHS score, while the bottom track shows the smoothed base counts. (D,E) Comparative analysis of
E15.5 DNaseI-seq andRNA-seq data. (D) RNA-seq data [log base 2 (transcripts per million (TPM+1))] fromE15.5 Sertoli cells was divided into quartiles based on
expression values [Q1, log2(TPM+1)=0-0.1; Q2, log2(TPM+1)=0.1-2.34; Q2, log2(TPM+1)=2.34-5.02; Q2, log2(TPM+1)=5.02-12.74]. The chart indicates the
number of genes within each quartile that had an overlapping DHS (blue) or did not have an overlapping DHS (gray) at the TSS. (E) Genes with aDHS overlapping
the TSS were divided into quartiles based on DHS scores (Q1-Q4, low to high DHS scores). The distribution of expression values for each group is shown as a
boxplot (excluding outliers).
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(Song et al., 2011), DHSs were determined to be in gene promoters
(23%), intergenic (31%) and genic regions (exons 10%, introns
36%), and displayed a median length of 330 bp (Fig. S1). Over
13,000 genes (∼60%) had a DHS peak overlapping a transcriptional
start site (TSS), whereas over 9000 TSSs (∼40%) lacked a DHS
peak. Two loci representing a gene expressed in Sertoli cells (Sox9)
and a granulosa-specific gene (Foxl2) displayed DNase signals of
differing magnitudes at their TSS (Fig. 1B,C), suggesting that the
DHS signal at the TSSmay correlatewith gene expression levels. To
examine this possibility, RNA-seq was performed on E15.5 Sertoli
cells (Table S1). Consistent with prior studies (Boyle et al., 2008a),
the presence and magnitude of a DHS peak at the promoter was
associated with increased gene expression values (Fig. 1D,E).
Further validating the quality of our data, we identified the only
known distal enhancer for a Sertoli cell-expressed gene: Sox9.
Although the Sox9 enhancer TES is likely over-represented in our
data set due to the multi-copy nature of transgene insertions in the
Sox9 (Tes)-CFP line, our DHS data identifies only the smaller
functional element, TESCO (Sekido and Lovell-Badge, 2008), as
having putative enhancer activity (Fig. 2A).
Identification of DHSs important for gene regulation in
Sertoli cells
Given the success of this experiment, we performed DNaseI-seq on
E13.5 Sertoli cells, a stage of development for which we have
extensive expression data (Nef et al., 2005; Bouma et al., 2007a,
Jameson et al., 2012b) (Table S2). Our E13.5 DNaseI-seq data
showed similar properties to the data from E15.5 Sertoli cells;∼71%
of the DHSs were shared between both data sets and had nearly
identical genomic distributions (Fig. S2A,B).
To identify the DHSs most relevant for gene expression during
testis development, we conducted DNaseI-seq on six other mouse
samples [primary skin fibroblasts, embryonic stem cells (ESCs),
adult kidney, liver, heart and brain]. To identify putative enhancers
important for gene expression in Sertoli cells, we used the six other
somatic cell types to classify E13.5 and E15.5 Sertoli cell DHSs as
unique (present in only Sertoli cells), shared (in Sertoli cells and in
one to five additional cell types) or common (in all cell types). For
example, at the Sox9 promoter, all cell types had a DHS (common
DHS); however, the TES enhancer was found only in the E13.5 and
E15.5 Sertoli cell datasets (unique DHS) (Fig. 2A). Twenty-seven
percent (21,743) of all E15.5 Sertoli cell DHSs and 25% (21,863) of
E13.5 Sertoli cell DHSs were common, with promoters accounting
for over half of the common sites (Fig. 2B; Fig. S2C). CTCF
binding sites are highly conserved across different cell types (Kim
et al., 2007a; Xi et al., 2007; Song et al., 2011) and, consistent with
this, CTCF-binding sites found in eight other cell types (Shen et al.,
2012) were enriched in the common DHSs (Fig. 2C). In fact, of the
common sites not overlapping a promoter, ∼75% overlapped a
CTCF binding site. The remaining DHSs were unique (E15.5: 29%;
23,548, E13.5: 32%, 28,133) to the Sertoli cell lineage or shared
(E15.5: 44%; 36,176, E13.5: 43%, 38,111). A high proportion of
unique (85%) and shared (73%) sites localized to intergenic or
intronic regions (Fig. 2B; Fig. S2B), and are likely to be important
regulators of gene expression in Sertoli cells.
Sertoli cell DHSs associate with Sertoli and pregranulosa
cell-expressed genes, whereas active enhancers are
enriched near Sertoli cell genes
The DHSs identified by DNaseI-seq correlate with several genomic
features, including promoters, enhancers, repressors and insulators
(Heintzman et al., 2007, 2009; Boyle et al., 2008a). To focus on
regions of the genome driving Sertoli cell-specific gene expression,
we conducted chromatin profiling for H3K27ac, a strong predictor
of active enhancer activity (Creyghton et al., 2010; Rada-Iglesias
et al., 2011). H3K27ac ChIP-seq on E13.5 Sertoli cells identified
>28,000 H3K27ac peaks, ∼70% of which overlapped a DHS in our
E13.5 Sertoli cell dataset (Fig. 3A, Fig. S4).
We predicted that active enhancers would be enriched around
Sertoli cell-expressed genes. To test this, the enrichment of DHSs,
or H3K27ac-positive DHSs, was examined around Sertoli cell-
expressed genes and compared against genes expressed in
pregranulosa and germ cells (Jameson et al., 2012b). Using a
nearest-neighbor approach (McLean et al., 2010), we assigned
Fig. 2. Identification of DHSs unique to the Sertoli cell lineage. (A) Comparison of the genomic region around Sox9 in E15.5 Sertoli cells versus other cell
types (fibroblast, ESC) and tissues (kidney, liver, heart, brain). The Sox9-CFP transgene is driven by the 3 kb TES enhancer (blue bar) located 13 kb upstream
from the Sox9 TSS. Enhancer activity was previously narrowed to a subregion of TES: the 1.3 kb TESCO element (Sekido and Lovell-Badge, 2008) (light-blue
bar). DNaseI-seq identifies a DHS (black bar) spanning the TESCO element that is unique to the Sertoli cell lineage, consistent with the expression pattern
of the transgene. Black bars above the track denote DHSs; Parzen scores are shown to the left of each track. (B) Based on their cell type specificity, E15.5 Sertoli
cell DHSs were divided into unique, shared or common. Each group was subcategorized based on genomic location (promoter, gray; intergenic, purple; intronic,
green; exonic, orange). (C) The percentage of DHSs overlapping CTCF sites based on the average overlap with eight previously generated CTCF ChIP-seq
data sets (Shen et al., 2012).
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DHSs to one or two neighboring genes (Fig. 3A) and the number of
DHSs (Fig. 3B,C) or H3K27ac-positive DHSs (Fig. 3D) was
counted around genes enriched in these cell types.
As expected, common DHSs were not preferentially enriched
around Sertoli-, pregranulosa- or germ cell-expressed genes
(Fig. 3B). However, there was a significant increase in the
number of cell type-specific (unique+shared) DHSs neighboring
both Sertoli and pregranulosa cell-expressed genes (Fig. 3C). The
similar enrichment of DHSs around Sertoli and pregranulosa cell-
expressed genes may reflect the shared developmental origin of the
supporting cell lineages, which have similar expression profiles just
a few days prior to our analysis (E10.5) (Nef et al., 2005; Munger
et al., 2013). DHSs around pregranulosa cell-expressed genes may
define sites where repression complexes are bound to silence the
alternative female pathway upon Sertoli cell differentiation.
H3K27ac-positive DHSs, which are indicative of active enhancers,
were significantly enriched specifically in neighboring Sertoli cell-
expressed genes (Fig. 3D), as expected. Additionally, we observed no
enrichment of cell type-specific DHSs or H3K27ac-positive DHSs
near germ cell-expressed genes, consistent with the unrelated origin
of this cell lineage. Thus, using DNaseI-seq, we identified thousands
of regulatory sites that are likely to be critical regulators of gene
expression during Sertoli cell differentiation. Additionally, ChIP-seq
for H3K27ac classified these into active enhancers (associated with
actively-expressed genes; H3K27ac-positive DHSs) or inactive
enhancers (DHS-positive only) (Table S2).
Sertoli cell DHSs are enriched for TFs important for
supporting cell development
To identify the TFs that bind putative Sertoli cell regulatory sites, we
conducted computational analysis of the sequences in the Sertoli
cell unique DHSs that did not overlap a promoter. We counted 6-
mers in these DHSs, and used these as features in an L1 logistic
regression classifier to classify these regions from length-matched
sites flanking these DHSs (Koh et al., 2007) (Fig. 4A). A similar
approach was shown to aid in the identification of sequence features
underlying enhancer function in other mammalian systems (Lee
et al., 2011). Our method is designed to identify enriched 6-mers
found in a substantial fraction of DHSs. However, similar to other
motif enrichment approaches, it is possible that it does not identify
TFs that play a significant role in Sertoli cell biology, but bind to
only a few locations.
Our analysis revealed 305 6-mers identified within Sertoli cell
unique DHSs that are highly predictive of whether a region will be
open specifically in Sertoli cells compared with flanking regions
[area under receiver operating characteristic curve (AuROC)=0.82]
Fig. 3. Enrichment of DHSs near Sertoli and pregranulosa cell-expressed genes. (A) Using GREAT (McLean et al., 2010) each gene was assigned a gene-
regulatory domain extending to the nearest 3′ and 5′ gene, but not overlapping the proximal promoter of either neighboring gene. Regulatory domains are shown
for three examples: a Sertoli cell-expressed gene (Sox8), a pregranulosa cell-expressed gene (Rpso1) and a germ cell-expressed gene (Piwil2). Using data from
E13.5 Sertoli cells, the three bars under the gene show the locations of common DHSs (top) and cell type-specific DHSs (middle) (vertical light-blue lines), or
H3K27ac-positive DHSs (bottom; vertical dark-blue lines) for each region. The light-blue track shows the DNaseI-Seq Parzen score (autoscaled) and the dark-
blue track showsH3K27 signal. Gene names are positioned adjacent to the TSS and other genes in the region are indicated in gray. (B-D) The correlation between
E13.5 DHS sites and genes expressed in male or female supporting cells was plotted. The DHSs that mapped to each gene’s regulatory domain were counted
and the distribution of peaks per domain is shown as a box plot (outliers excluded). The results are shown for common DHSs (B), cell-type specific DHSs (C) and
H3K27ac-positive DHSs (D). mm9 refers to all RefSeq genes (light gray); GUDMAP is the subset of mm9 genes that were analyzed in our previous microarray
study [gray (Jameson et al., 2012b)]. Sertoli cell genes (blue), pregranulosa cell genes (red) and germ cells genes (green) categories are described in the
supplementary Materials and Methods. Statistical significance was calculated using a two-sample Mann–Whitney (two-sided) test to compare each gene set to
the GUDMAP reference set. *P<1×10−5, **P<1×10−10, ***P<2.2×10−16.
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(Fig. 4B). To rule out the possibility of high classification accuracy
due to repeats in flanking regions, we trained a classifier to
distinguish Sertoli cell DHSs from a union set of unique DHSs from
other cell types, including ES and fibroblast cells, and heart, kidney,
liver and brain tissue. The classifier again showed high classification
accuracy (AuROC=0.87). Furthermore, the 6-mers identified are
similar between the two classification tasks, indicating that the
features identified are robust predictors of Sertoli cell-specific DHSs
(Table S3A,D).
We used TOMTOM (Bailey et al., 2009) to identify TFs that
match these 6-mer motifs and found 75 6-mers matching known
motifs. As multiple TFs have similar motifs, we used Sertoli cell
gene expression (Jameson et al., 2012b) to identify the most likely
candidates. The 6-mer most predictive of open chromatin in Sertoli
cells matched the TF-binding motif for SF1 (Fig. 4C, Table S3), a
factor required for early gonad formation in both sexes (Luo et al.,
1994; Baba et al., 2014). Other prominent motifs identified include
the SOXmotif, which reflects the crucial role of SOX9 and SOX8 in
the divergence of the Sertoli cell lineage from the undifferentiated
progenitor cells (Chaboissier et al., 2004; Barrionuevo and Scherer,
2010), and the GATA motif, likely representing GATA4 (which is
involved in early gonadal differentiation in both sexes) (Bouma
et al., 2007b; Manuylov et al., 2008). Matches to SF1, SOX9 and
GATA4 motifs were also found to be statistically enriched in
Sertoli cell-specific DHSs, supporting the validity of our method
(Table S3E). Although less predictive of open chromatin, the FOX
and TCF/LEF motifs were also identified (Table S3). FOXL2
(Schmidt et al., 2004; Ottolenghi et al., 2005) and Wnt signaling
(which modulates gene expression through β-catenin binding with
TCF/LEF factors) (Vainio et al., 1999; Chassot et al., 2008; Liu
et al., 2009) are female-specific factors that are important for
pregranulosa cell differentiation; enrichment of these motifs in
Sertoli cell open chromatin may indicate sites requiring repression
during Sertoli cell differentiation.Also identified was ELF1, an Ets-
related TF. Ets family TFs can act downstream of FGF signaling
(Sharrocks, 2001), which is crucial for repressing Wnt signaling to
reinforce testis development (Kim et al., 2006; Jameson et al.,
2012a). Additionally, we identified 6-mers matching TFs that are as
yet not known to play a role in Sertoli cells, including TEAD1 and
ZBTB33, as well as 6-mers that show no similarity to any known
TF-binding motif (Table S3).
To determinewhether distinct sequence features could differentiate
active from inactive enhancers, we again used the L1-logistic
regression classifier to classify the active enhancers (H3K27ac-
positive DHS) from inactive DHSs (H3K27ac-negative DHS). The
performance of the classifier was significantly reduced compared
Fig. 4. TF-binding sites in active enhancers and inactive DHSs. (A) Schematic representation of the classification approach to identify motifs and TFs
predictive of Sertoli cell DHSs. The top enriched motifs with known binding factors for sites predictive of DHS versus flank (left) and active versus inactive DHSs
(right) are shown. (B) AuROC for different L1-logistic regression classifiers. Classifying active enhancers and inactive DHS against flanking regions shows high
classifier performance (∼0.82), while classifying active enhancers against inactive DHS shows lower performance (∼0.67). (C-E) Top motifs driving predictive
performance for the different classification tasks. TFs shown are best hits from the MEME suite’s TOMTOM tool matching to the different 6-mers (Gupta et al.,
2007). The prevalence ratio is defined as: the ratio of the average length normalized frequency of that 6-mer in DHSs unique to Sertoli cells relative to the flanking
regions (C); the ratio of the average length normalized frequency of that 6-mer in active enhancers to inactive DHSs (D); the ratio of the average length normalized
frequency of that 6-mer in inactive DHSs to active enhancers (E). The top 10 6-mers are shown in order of the absolute value of their regression coefficients. Only
the first 6-mer matching to a particular TF is shown. TFs identified in D and E were identified in the same classifier, with those TFs shown in D more highly
prevalent in active enhancers and those in E more prevalent in inactive DHSs. Table S3 contains the complete results for the analyses in C-E.
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with our previous classifiers (AuROC=0.67), indicating that, despite
the fact that active enhancers drive expression in Sertoli cells,
sequence features between active enhancers and inactive DHSs are
more similar than those betweenDHS and flanking regions (Fig. 4B).
Inspection of the 6-mers that facilitate prediction of one class versus
the other revealed 80 6-mers predictive of active enhancers and 64 6-
mers predictive of inactive DHSs, many of which are not associated
with a known TF. However, of the 6-mers predictive of an active
enhancer, 25 did match a known motif. DBP, GATA4, FOXL1 and
other FOX factor motifs were among the most predictive motifs for
active enhancers (Fig. 4D). Although GATA4 is a well-known driver
of Sertoli cell development (Bouma et al., 2007b), the role of DBP is
unknown. Our identification of FOX motifs is consistent with a role
of FOXL2 in repression of a Sox9 enhancer (TESCO) in granulosa
cells after birth (Uhlenhaut et al., 2009) and suggests that FOXL2
may play a similar role earlier in fetal development (see Discussion).
Alternatively, several other FOX factors are expressed in both Sertoli
and pregranulosa cells (Jameson et al., 2012b) that have yet to be
characterized and could bind these sites.
In addition, the same analysis identified 20 6-mers with matching
motifs that were more predictive of inactive DHSs compared with
active enhancers. Although we did not identify motifs associated
with known pregranulosa cell-specific TFs, the H3K27ac-negative
DHSs likely represent a diversity of open chromatin sites,
potentially associated with many genes that are repressed or
poised in Sertoli cells, with or without sex-specific functions
(Fig. 4E). Interestingly, some of the highest scoring 6-mers in this
group were not associated with known binding factors.
The motif for another TF important for Sertoli cell development,
DMRT1, did not come up as predictive of open chromatin in this
analysis. However, we used available ChIP-seq data from E13.5
whole testes to analyze the enrichment of DMRT1-bound sites in
Sertoli cell open chromatin (Matson and Zarkower, 2012). We
found that 70% of DMRT1 sites overlapped a DHS in our Sertoli
cell dataset. However, the majority of DMRT1 sites overlapped
promoters, with only 30% overlapping Sertoli cell unique and
shared sites (Fig. S3). The exclusion of promoters from our 6-mer
motif analysis may account for the absence of DMRT1 enrichment
in DHSs analyzed.
DNaseI-Seq identifies a novel enhancer of Sertoli cell gene
expression nearWt1
With the exception of the TESCO element, few distal regulatory
elements have been identified for sex-determining genes. Our dataset
provides an excellent resource with which to identify enhancers
driving the expression of genes important in Sertoli cell
differentiation. To demonstrate this, we performed a transient
transgenic assay with a putative active enhancer of the Wt1 gene
(Fig. 5A,B).Wt1 is initially expressed in multiple embryonic tissues,
including the mesonephros and XX and XY gonadal somatic cells.
Mutation of Wt1/WT1 in mice and humans leads to kidney and
genitourinary defects, including disorders of sexual development
(Kreidberg et al., 1993; Eggers and Sinclair, 2012). After sex
determination, Wt1 expression becomes restricted to Sertoli cells in
the testis and remains active in most somatic cells in XX gonads
(Pelletier et al., 1991; Armstrong et al., 1993; Maatouk et al., 2012).
We identified a DHS peak located 50 kb upstream of Wt1 that was
unique to E13.5 and E15.5 Sertoli cells compared with the other cell
types we examined, and marked by H3K27ac, suggesting that it
functions as an active enhancer. Finally, this region contained
matches to several of the 6-mers identified in our motif analysis,
including binding sites for SF1, SOX and FOX motifs.
Analysis of in vivo enhancer activity using a transgenic
β-galactosidase reporter showed that the putative Wt1 enhancer
Fig. 5. Transient transgenic analysis of a DHS unique to Sertoli cells identifies a new Sertoli cell enhancer upstream ofWt1. (A) DNaseI-seq and
H3K27ac ChIP-Seq data around theWt1 locus. Gene names indicate the TSS of the transcript. Nearby genes are indicated in gray. DNaseI-Seq data (Parzen
score) and peak calls (boxes above track) are in light blue; H3K27ac ChIP-seq data and peak calls are in dark blue. A box surrounds the DHS chosen for in vivo
analysis. (B) Detailed view of the DHS showing the DNaseI-seq Parzen score, the smoothed base counts (light blue) and the H3K27ac data (dark blue). The light-
and dark-blue bars indicate the DNaseI-seq and H3K27ac peaks, respectively. The black bar marks the region cloned upstream of an hsp68-LacZ reporter
cassette. (C) An E13.5 testis from a transgenic embryo showed β-galactosidase expression (TgWt1, green) specifically in Sertoli cells. Sertoli cells were labeled
by AMH immunostaining (red) and germ cells by CDH1 (blue). The confocal imagewas taken using a 20× objective. Scale bar: 100 µm. (D) Confocal image of the
sample in C taken with a 40× objective. Scale bar: 12.5 µm. All three panels show germ cells (blue); the left panel shows Sertoli cells (red); themiddle panel shows
β-galactosidase expression (green); the right panel shows the merge (yellow indicates co-expression of β-galactosidase and AMH).
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was active in Sertoli cells of the testis (6/7 transient transgenic XY
embryos; Fig. 5C,D and Fig. S5), where it exclusively localized in
cells expressing the Sertoli cell marker AMH. Expression was also
detected in somatic cells of the ovary (11/12 XX embryos; Fig. S5).
However, no expression was detected in the mesonephros,
embryonic kidney, heart or brain (Fig. 5C, Fig. S5 and data not
shown) consistent with the cell-type specificity of this enhancer in
our Sertoli cell datasets. These results demonstrate the power of our
approach for the identification of distal enhancers that activate
transcription in Sertoli cells.
DISCUSSION
Identification of Sertoli cell gene regulatory sites
Understanding the genetic networks that underlie developmental
processes requires a comprehensive understanding of the genes
involved as well as the regulatory mechanisms that modulate the
expression of these genes. This is among a small number of studies
to adapt epigenetic approaches, including DNaseI-seq and ChIP-
seq, to address the resolution of cell fate in a cell type isolated from a
complex developing tissue.
To discover cis-regulatory sequences during sex determination,
we used DNaseI-seq to identify open chromatin sites and H3K27ac
ChIP-seq to identify active enhancers in Sertoli cells. Using these
data, we discovered TFs that might bind to these sites. We identified
a novel active enhancer unique to Sertoli cells upstream of Wt1, and
showed that it functions as a specific Sertoli cell enhancer in
transgenic animals, as predicted. These data will enable future
studies of cis-regulatory elements in Sertoli cells.
Although we were able to reduce the number of cells required for
DNaseI-seq to 5 million cells, collection required more than 1 year,
considering that a pair of E13.5 fetal testes contains only 10-20,000
Sertoli cells. Unfortunately, our attempts to perform DNaseI-seq on
pregranulosa cells failed, possibly owing to the longer storage times
required to collect sufficient numbers of cells (our pregranulosa cell
reporter enabled purification of only 2-4000 cells per embryo).
Rather than identifying sites of open chromatin based on DNaseI-
seq, a new technique, ATAC-seq, uses a transposome-based method
where the transposome preferentially integrates into sites of open
chromatin (Buenrostro et al., 2013) and is highly correlative with
DNaseI-seq data. Working on as few as 500 cells, this method
presents an attractive alternative to enable studies of chromatin
during cellular differentiation. Future studies will address whether a
common chromatin architecture is maintained in differentiated XX
and XY supporting cells, or whether these sites are eventually
remodeled in a sexually dimorphic manner as differentiation
proceeds.
DHSs adjacent to pregranulosa cell genes might indicate
TF-mediated repression in Sertoli cell fate maintenance
In multipotent progenitor cell types, many developmentally
regulated genes exist in an epigenetically poised state. Cis-
regulatory elements of poised genes are marked by H3K4me1 and
open chromatin (Heintzman et al., 2007). Upon differentiation,
regulatory sites for active genes gain H3K27ac (Creyghton et al.,
2010; Rada-Iglesias et al., 2011) and retain open chromatin, while
repressed genes either remain poised or exhibit a loss of H3K4me1
and open chromatin (Whyte et al., 2012; Lara-Astiaso et al., 2014),
perhaps rendering regulatory sites refractory to access by TFs.
In bipotential progenitor cells of the gonad, it is currently
unknown whether genes that become sex-specific exist in an
epigenetically poised state prior to sex determination. However, we
hypothesized that, by E13.5, when sex-specific gene expression
patterns are well-established, open chromatin would be enriched
near genes actively expressed in Sertoli cells. Although the
enrichment of H3K27ac-positive active enhancers was associated
with only Sertoli cell-expressed genes as expected, an intriguing
finding was thewidespread enrichment of DHSs around both Sertoli
and pregranulosa cell-expressed genes in E13.5 differentiated
Sertoli cells. There is evidence that many genes associated
specifically with ovarian development are expressed in both sexes
at the bipotential stage, suggestive of lineage priming (Jameson
et al., 2012b), and initiation of the male pathway is characterized
by extensive upregulation of the testis-pathway genes with
simultaneous downregulation of ovarian-pathway genes. In
contrast, transcriptional priming of pregranulosa progenitors
towards the female pathway results in fewer transcriptional
changes upon differentiation (Munger et al., 2009; Jameson et al.,
2012b). One possible explanation for the retention of open
chromatin near repressed pregranulosa cell genes in Sertoli cells is
that loss of open chromatin sites occurs slowly, downstream of
faster transcriptional changes. At a later developmental stage,
fewer open chromatin sites might be associated with repressed gene
loci. During ES cell differentiation, reduced H3K4me1 and open
chromatin domains were observed near repressed genes within 48 h
of differentiation (Whyte et al., 2012; Buecker et al., 2014).
However, in multiple hematopoietic lineage descendants, the loss of
open chromatin near repressed genes did not occur until late
differentiation stages (Lara-Astiaso et al., 2014). We observed a
similar enrichment of DHSs around both Sertoli and pregranulosa
cell genes at E13.5 and E15.5 (Fig. S2), up to 4 days after peak
Sry expression. Although it remains possible that a loss of open
chromatin near repressed pregranulosa cell genes occurs later in
adult Sertoli cells, an alternative possibility is that open chromatin
regions persist near granulosa-expressed genes, perhaps reflecting
the original bipotential progenitor capable of differentiating as a
Sertoli or granulosa cell. Open chromatin near granulosa genes
could be bound either by TFs that function to preserve a poised
chromatin state or bound by repressive TFs that maintain the Sertoli
cell fate. It is unclear whether this is a generalizable feature of cell
populations that derive from a common bipotential progenitor.
An intriguing characteristic of gonadal supporting cells is that long
after sex determination, some mutations cause transdifferentiation to
the alternate cell fate. In the testis, Dmrt1 is required to prevent
postnatal Sertoli to granulosa cell transdifferentiation by repression of
several pregranulosa cell genes, including Foxl2, Esr2 and β-catenin
(Matson et al., 2011; Minkina et al., 2014). In a reciprocal manner,
mutation ofFoxl2 causes granulosa-to-Sertoli cell transdifferentiation
in the adult ovary (Schmidt et al., 2004; Ottolenghi et al., 2005). Our
finding that Sertoli cells maintain open chromatin near many
repressed granulosa genes might suggest that continued repression
by TFs represents a mechanism for long-term maintenance of the
Sertoli cell fate, and that these repressive mechanisms are established
early during Sertoli cell development. Consistent with this, the
TESCO enhancer of Sox9 is bound by FOXL2 in adult granulosa cells
(Uhlenhaut et al., 2009), where Sox9 is silenced; however, it is bound
by SRY/SOX9 and SF1 in Sertoli cells (Sekido and Lovell-Badge,
2008), where Sox9 is active. The use of the same cis-regulatory
element to repress expression (via FOXL2 binding) in granulosa cells
and activate expression (via SRY/SOX9 and SF1 binding) in Sertoli
cells suggests that at least some cis-regulatory sites serve a dual
purpose during sex-specific differentiation.
If the same regulatory sites act as enhancers in one cell type
and repressors in the opposing cell type, then motifs for both
male-promoting and female-promoting TFs would be located
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within the active enhancers of Sertoli cell genes, available for
competitive occupancy by male- or female-promoting TFs.
Consistent with this, our motif analysis discriminating active
versus inactive enhancers identified both the SOX and FOX motifs
as predictive of active enhancers in Sertoli cells (Fig. 4 and
Table S3). Furthermore, the lack of high classification accuracy
from simple sequence features in active enhancers and inactive
DHSs points to a complex and combinatorial regulatory code.
Alternatively, differences in protein concentrations or post-
translational modifications to regulators might explain the
different transcriptional programs. The dual use of enhancers,
such as TESCO,may underlie the ability of gonadal supporting cells
to switch fates; however, it is currently unclear how extensive this
mechanism is. Future studies mapping open chromatin sites in
granulosa cells will reveal whether shared cis-regulatory sites
represent a subset of gene regulatory mechanisms, or whether open
chromatin sites are extensively shared between these functionally
and morphologically distinct cell lineages.
Regulatory sites may harbor non-coding mutations that
cause DSDs
The inability to provide a genetic diagnosis for the majority of
individuals with a DSD has led to the development of more robust
diagnostic tests to screen large regions of the genome for potential
disease-causing mutations, including exome sequencing and copy
number variation arrays (White et al., 2011; Arboleda et al., 2013;
Baxter et al., 2015). This approach has revealed non-coding
mutations upstream of SOX9 that result in DSDs (Kim et al., 2015).
However, identifying non-coding mutations on a genome-wide
scale remains difficult, and classification of non-coding mutations
as potentially disease-causing is challenging, as these mutations do
not directly alter the protein sequence. Recent studies have
attempted to identify human enhancers for this purpose, using
publicly available data from the NIH Roadmap Epigenomics
Program (Roadmap Epigenomics Consortium et al., 2015). DNaseI-
seq datasets for human fetal ovary and testis tissue have been used to
identify putative enhancers (Ohnesorg et al., 2016). These tissues
were presumably collected well after 4-6 weeks of gestation, the
stage at which sex determination occurs in humans, and it is
currently unclear whether enhancers that operate at the sex-
determining stage are maintained in the late fetal stages. These
issues can be addressed in mice; however, future studies will need to
determine the extent of functional conservation between mouse and
human enhancers. The genome-wide identification of regulatory
sites that function during sex differentiation will enable more
detailed studies on the regulation of sex-determining genes and will
identify candidate regions that might harbor disease-causing
mutations in humans with DSDs.
MATERIALS AND METHODS
Mouse strains, matings and cell/tissue isolation
To isolate Sertoli cells, Sox9-ECFP homozygous transgenic males (Kim
et al., 2007b) were bred to CD-1 (Charles River) females in timed matings to
generate E13.5 and E15.5 embryos. Following sorting by FACS, the cell
pellet was snap-frozen and stored at −80°C for RNA-seq. For DNaseI-seq,
cell pellets from the CFP-positive and CFP-negative fractions were
resuspended in 250 µl of recovery-cell culture freezing media (Gibco) and
slowly frozen to −80°C.
Mouse tissues (kidney, liver, heart, and brain) were collected from adult
B6 mice. The B6 strain mouse fibroblast cell line was commercially
available (Jackson Labs) and B6 strain ESCs were kindly provided by
Ute Hochgeschwender (Duke University). For further details see the
supplementary Materials and Methods.
Mice were housed in accordance with National Institutes of Health
guidelines, and experimental protocols were approved by the Institutional
Animal Care and Use Committee of Duke University Medical Center.
DNaseI-seq assay and data processing
DNaseI-seq assay was performed as previously described (Boyle et al.,
2008a; Song and Crawford, 2010) with few modifications. DNaseI-seq
libraries were prepared and data processed as previously described (Boyle
et al., 2008b; Li and Durbin, 2009, Song and Crawford, 2010; Song et al.,
2011). For further details see the supplementary Materials and Methods.
RNA preparation and RNA-seq data processing
E15.5 Sox9CFP-positive cells were pooled into three independent
biological replicates containing ∼1 million cells. RNA isolation was
performed using the RNeasy Micro Kit according to the manufacturer’s
protocol (Qiagen). Poly-A enriched mRNA libraries were generated from
0.8-1 µg of RNA using the standard Illumina Tru-Seq V2 protocol and
sequencing was carried out by the Duke Genome Sequencing and Analysis
Core.
RNA-seq data was processed using Bowtie version 0.12.7 (Langmead
et al., 2009) and RSEM version 1.2.0 (Li and Dewey, 2011) as described in
the supplementary Materials and Methods. RSEM expected counts were
quartile normalized and square-root transformed.
TSS and regulatory domain assignments
Transcriptional start and end sites were downloaded from the UCSC
Genome browser and used to generate regulatory domains using GREAT
(McLean et al., 2010). For further details see the supplementary Materials
and Methods.
Genomic location assignments
DHSs were assigned to specific genomic locations using previously
published methods (Song et al., 2011). For further details see the
supplementary Materials and Methods.
Cell type specificity categorization
Cell type specificity was determined by comparing DHSs from DNaseI-seq
datasets from other cell types using the BedTools Software suite (Quinlan
et al., 2010). For further details see the supplementary Materials and
Methods.
CTCF overlap
We used previously published CTCF ChIP-seq datasets (Shen et al., 2012)
and compared these against Sertoli-unique, Sertoli-specific and Sertoli-
common DHSs using BedTools. For further details see the supplementary
Materials and Methods.
DMRT1-binding site enrichment analysis
We used previously published DMRT1 ChIP-seq data (Krentz et al., 2013)
and assessed overlap with Sertoli DHSs using BedTools. For further details
see the supplementary Materials and Methods.
Enrichment of DHSs in Sertoli cell-expressed genes
To calculate enrichment, we assessed the number of DHSs that were
assigned to each gene's regulatory domain. DHSs were divided as common,
unique+shared or active enhancers (H3K27ac-positive). Significance was
calculated using a two-sided Mann-Whitney test. For further details see the
supplementary Materials and Methods.
Transient transgenics, immunocytochemistry and imaging
Aputative regulatory region upstream ofWt1was amplified and cloned into the
Hsp68-LacZ reporter vector (Addgene; Plasmid #33351). DNA was prepared
for zygote injection, and resuspended in EmbryoMax Injection Buffer
(Millipore, MR-095-10F). Pronuclear injections into B6SJLF1/J zygotes
were performed by the Duke Transgenic Core Facility to generate transient
transgenics. Embryos were dissected at E13.5 and genotyped for theLacZ gene
For immunostaining, fixed gonads were processed as previously described
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(Maatouk et al., 2012). Antibodies were used at the following dilutions: rat-
anti-CDH1, 1:250 (Zymed, 13-1900); rabbit-anti-β-galactosidase, 1:10,000
(MP Biomedicals, 55976); goat-anti-MIS/AMH, 1:250 (Santa Cruz, sc-6886);
Alexa Fluor 488-anti-rat, 1:500 (Molecular Probes, A21208); Cy3-anti-rabbit,
1:500 (Jackson ImmunoResearch Laboratories, 711-165-15); Alexa Fluor 647-
anti-goat, 1:500 (Molecular Probes, A21447). For further details see the
supplementary Materials and Methods.
ChIP-seq assay and data processing
For ChIP-seq, FACS-purified Sertoli cells were pelleted, resuspended,
crosslinked and stored at −80°C. Briefly, 1 million cells were pooled from
multiple sorts, washed, lysed, sonicated and incubated with bead-antibody
complexes with 2.5 µg antibody (Rabbit-anti-H3K27ac; Abcam ab4729).
Library preparation was performed on immunoprecipitated chromatin using
the Rubicon ThruPLEX FD kit according to the manufacturer’s protocol.
Sequencing was performed at Duke’s Genome Sequencing and Analysis
core facility.
ChIP-seq reads were uniquely aligned with Bowtie (Langmead et al.,
2009); peaks were called with SICER (Zang et al., 2009) using the input
track as the control. For further details see the supplementary Materials and
Methods.
Sequence analysis to identify predictive 6-mers and matching
motifs
Enriched motifs were identified by incorporating previous methods (Lee
et al., 2011; Natarajan et al., 2012). 6-mers and their reverse complements,
were counted in each region, normalized by the length of the region, and
used as features for an L1-norm sparse logistic regression classifier (Koh
et al., 2007). Ten randomized iterations of fourfold cross-validation were
performed to generate 40 different partitions of the data. 6-mers that showed
non-zero regression coefficients in over 75% of the partitions were deemed
to be significant and are shown in Table S3A-D. 6-mers were matched to
known TF PWMs with TOMTOM (Gupta et al., 2007) using the JASPAR
core vertebrate motifs, the UNIPROBE database and those generated by
Jolma et al. (Bryne et al., 2007; Jolma et al., 2013; Hume et al., 2015). The
SF1 (Baba et al., 2014) and DMRT1 (Krentz et al., 2013) motifs were
included. For further details see the supplementary Materials and Methods.
Analysis of significance of motif matches
We used FIMO from the MEME Suite (Grant et al., 2011) to scan different
regions of the genome. Length normalized motif match scores were used in a
one-sided Mann-Whitney U-test to test for significance. For further details
see the supplementary Materials and Methods.
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